CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 6 enrolled
Drug / intervention
venlafaxinedrug
Likely dose
venlafaxine 150mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00634283
NCT00634283Phase 4Completed
CompareCT.gov

Physiologic Monitoring of Antidepressant Medication Effects in Normal Healthy Subjects II

University of California, Los Angeles·interventional·Posted Mar 13, 2008·Updated Mar 9, 2020

In Brief

A Phase 4 clinical trial evaluating venlafaxine for Depression. Completed, enrolled 6 participants across 1 site.

Detailed Summary

This study examines the effects of an antidepressant medication and placebo on the brain functioning of normal subjects. In this study, recordings of brain electrical activity are being used to detect and monitor the response to treatment with venlafaxine IR (Effexor), a drug used for the treatment of depression. The intent of this study is to test specific hypotheses regarding: 1. long-term brain effects of a single course of antidepressant treatment 2. pharmaco-conditioning effects underlying antidepressant tolerance/sensitization 3. brain functional response to initial versus subsequent antidepressant trials in normal healthy subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 13, 2008
Enrollment StartFeb 1, 2008
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 18.3 years ago

Interventions

venlafaxinedrug

venlafaxine IR 150mg